Key Highlights

  • FuelCell Energy Inc (NASDAQ: FCEL) agreed to sell 10,714,286 common shares at $21.00 per share.
  • Proceeds of approximately $245.4 million are intended for manufacturing expansion, working capital, and general corporate purposes.
  • FuelCell Energy Inc (NASDAQ: FCEL) announced on July 7, 2026 a definitive underwriting agreement that sets out the terms of a public offering of its common stock.

FuelCell Energy Inc (NASDAQ: FCEL) announced on July 7, 2026 a definitive underwriting agreement that sets out the terms of a public offering of its common stock. The agreement provides for the issuance of 10,714,286 shares, each bearing a nominal $0.0001 par value, priced at $21.00 per share for the public.

Offering Overview

The underwritten transaction targets a total of 10,714,286 shares of FuelCell Energy’s common stock. The pricing reflects current market conditions for companies operating in the fuel‑cell and clean‑energy sectors, where demand for scalable power solutions continues to grow. Investors will receive shares with a minimal par value, a standard practice for equity offerings of this type.

Pricing and Option Details

Beyond the primary issuance, the underwriting agreement grants the syndicate a thirty‑day option to acquire up to 1,607,143 additional shares at the same $21.00 price. This provision gives the underwriters flexibility to meet potential excess demand without altering the offering price.

Underwriters and Agreements

Citigroup Global Markets and Barclays Capital serve as the lead underwriters, coordinating the placement of the shares with the broader underwriting syndicate. The agreement incorporates customary representations, warranties, and indemnification clauses designed to protect all parties under the Securities Act of 1933.

Use of Proceeds

FuelCell Energy intends to apply the estimated $245.4 million of net proceeds toward capital expenditures that will broaden its manufacturing capacity, support ongoing working‑capital needs, and fund general corporate initiatives. The infusion of capital is expected to enhance the company’s ability to meet the rising demand for clean‑energy solutions across multiple markets.

Regulatory Filings

The offering is registered under the Securities Act via registration statement No. 333‑296607, which became effective upon filing. Required prospectus documents were submitted in accordance with Rule 424(b).

Closing Timeline

The transaction is slated to close in early July 2026, contingent upon the satisfaction of standard closing conditions. Upon completion, the newly issued shares will be allocated to the underwriting syndicate and placed with investors in the public market.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.